Scottish Post Menopausal Chemo-Endocrine Trial
ISRCTN | ISRCTN51555498 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN51555498 |
Secondary identifying numbers | BR9402 |
- Submission date
- 19/08/2002
- Registration date
- 19/08/2002
- Last edited
- 11/01/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr - -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Scottish Post Menopausal Chemo-Endocrine Trial |
Study objectives | Not provided at time of registration |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Breast cancer |
Intervention | Following surgery patients are randomised to one of two treatment groups: 1. Group A: Tamoxifen 20 mg daily for 5 years 2. Group B: Tamoxifen 20 mg daily for 5 years plus six cycles of CMF (cyclophosphamide, methotrexate, 5-fluorouracil) chemotherapy |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | Tamoxifen |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/01/1995 |
Completion date | 30/09/2000 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | 1. Histologically confirmed invasive carcinoma of the breast 2. Post-menopausal 3. Aged <70 years 4. No medical contraindications to treatment |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/01/1995 |
Date of final enrolment | 30/09/2000 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
Scottish Cancer Therapy Network (UK)
Research organisation
Research organisation
Trinity Park House
South Trinity Road
Edinburgh
EH5 3SQ
United Kingdom
Funders
Funder type
Research organisation
Scottish Therapy Network (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
11/01/2016: no publications found on PubMed.